SAFETY, TOLERABILITY AND BIOEQUIVALENCE ASSESSMENT OF A DISPERSIBLE TABLET FORMULATION OF PYRAZINAMIDE

Abstract

Pyrazinamide is a widely used drug for the treatment of tuberculosis. A 150 mg Dispersible Tablet (DT) formulation of the drug was prepared by Micro Labs, a generic drug company. The formulation was developed for easy administration into paediatric patients. It was tested for bioequivalence in healthy adult human volunteers in fasting condition. A total of 36 subjects were enrolled in the study and all the 36 subjects completed both the two periods of the study without showing major adverse events. The pharmacokinetic parameters determined for bioequivalence were Cmax and AUC0-t. The two parameters were within the limit of bioequivalence criteria. The 150 mg DT formulation developed by Micro Labs was found to be bioequivalent to 500 mg immediate release tablet formulation of Riemser Pharma. Both the formulations were safe and well tolerated among the tested human subjects. No major adverse events were observed.

Authors and Affiliations

Atreyee Sarkar, Mrunal S Davey, Atul Savalia, Shivanand Dhanure

Keywords

Related Articles

SPRAY DRYING: A APPROACH FOR SOLUBILITY ENHANCEMENT OF RITONAVIR BY SOLID DISPERSION

The aim of present work was to improve the dissolution rate of Ritonavir by preparing micro-particles with certain hydrophilic polymers via spray drying technique. Role of spray drying method was studied for solubility e...

FORMULATION, CHARACTERIZATION AND IN VITRO EVALUATION OF ENTACAPONE SOLID DISPERSIONS WITH LIPID CARRIERS BY USING SPRAY DRYING METHOD

In present study, immediate release solid dispersion formulation of Entacapone with various lipids was developed using spray drying method. Entacapone is indicated for the treatment of Parkinson’s disease (PD) as an adju...

A NOVEL RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF TRIFLUOPERAZINE AND ISOPROPAMIDE IN TABLET DOSAGE FORM

The present paper describes a reverse phase HPLC method for simultaneous estimation of Trifluoperazine and Isopropamide from their combined tablet dosage form. The proposed RP-HPLC method utilizes an Agilent Zorbax, C18...

SYNTHESIS, CHARACTERIZATION AND ANTIMICROBIAL ACTIVITY OF ZINC OXIDE NANOPARTICLES SYNTHESIZED FROM CALOTROPIS PROCERA

The aim of the study was to compare the yield, nature and antimicrobial activity of nanoparticles synthesized using Calotropis procera leaf extract. ZnO NPs synthesized were characterized by FTIR and SEM. It was evident...

COMPARATIVE BIOAVAILABILITY STUDY WITH TWO SODIUM VALPROATE TABLET FORMULATIONS IN HEALTHY SUBJECTS

The aim was to assess the comparative bioavailability of two formulations (200 mg tablet) of sodium valproate in healthy subjects. This open label randomized, two periods, two treatments, two sequence, 2-way crossover de...

Download PDF file
  • EP ID EP618308
  • DOI 10.25004/IJPSDR.2017.090503
  • Views 79
  • Downloads 0

How To Cite

Atreyee Sarkar, Mrunal S Davey, Atul Savalia, Shivanand Dhanure (2017). SAFETY, TOLERABILITY AND BIOEQUIVALENCE ASSESSMENT OF A DISPERSIBLE TABLET FORMULATION OF PYRAZINAMIDE. International Journal of Pharmaceutical Sciences and Drug Research, 9(5), 220-223. https://europub.co.uk/articles/-A-618308